Skip to main navigation Skip to search Skip to main content

Adaptive Design for Phase II/III Platform Trial of Lassa Fever Therapeutics

  • Josephine Bourner*
  • , Michel Vaillant
  • , Alex Paddy Abdel Salam
  • , Marie Jaspard
  • , Camille Fritzell
  • , Shevin T Jacob
  • , Tom E Fletcher
  • , Michael Ramharter
  • , Nnennaya Ajayi
  • , Sylvanus Okogbenin
  • , Cyril Erameh
  • , Donald Grant
  • , Robert Samuels
  • , Oladele Oluwafemi Ayodeji
  • , Armand Sprecher
  • , Bronner P Gonçalves
  • , Tansy Edwards
  • , Piero Olliaro
  • , WALC Work Package 2 Working Group
  • *Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

Fingerprint

Dive into the research topics of 'Adaptive Design for Phase II/III Platform Trial of Lassa Fever Therapeutics'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases